STAT3 and non-small cell lung carcinoma: Moreover, both the GR activity and expression was found to be modulated upon drug treatment which may suggest that OP-D may primarily exert its STAT3 inhibitory and pro-apoptotic effects via a redox-regulated mechanism in NSCLC cells.